Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the beginning of 2018. Several of the CTS client forms specify list the Medical Director in the header and these forms will be updated on March 5, 2018. Check out the Communication page for a complete list of forms or by clicking the link below: Communications
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...